EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Interleukin-6 Activation and Arthritis on Epidermal Growth Factor Receptor (EGFR) Activation in Sensory Neurons and the Spinal Cord

Anutosh Roy iD, Gisela Segond von Banchet, Fátima Gimeno-Ferrer, Christian König iD, Annett Eitner iD, Andrea Ebersberger iD, Matthias Ebbinghaus, Johannes Leuchtweis, Hans-Georg Schaible iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25137168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anutosh Roy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology 1/Neurophysiology, Jena University Hospital, Friedrich-Schiller-University, 07743 Jena, Germany. Hauptthemen laut MEDLINE: ErbB Receptors, Interleukin-6, Sensory Receptor Cells, Spinal Cord. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union`s Horizon 2020 Research and Innovation Programme, European Union’s Horizon 2020 research and innovation program, Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, program Neuroimpa).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In tumor cells, interleukin-6 (IL-6) signaling can lead to activation of the epidermal growth factor receptor (EGFR), which prolongs Stat3 activation. In the present experiments, we tested the hypothesis that IL-6 signaling activates EGFR signaling in peripheral and spinal nociception and examined whether EGFR localization and activation coincide with pain-related behaviors in arthritis. In vivo in anesthetized rats, spinal application of the EGFR receptor blocker gefitinib reduced the responses of spinal cord neurons to noxious joint stimulation, but only after spinal pretreatment with IL-6 and soluble IL-6 receptor. Using Western blots, we found that IL-6-induced Stat3 activation was reduced by gefitinib in microglial cells of the BV2 cell line, but not in cultured DRG neurons. Immunohistochemistry showed EGFR localization in most DRG neurons from normal rats, but significant downregulation in the acute and most painful arthritis phase. In the spinal cord of mice, EGFR was highly activated mainly in the chronic phase of inflammation, with localization in neurons. These data suggest that spinal IL-6 signaling may activate spinal EGFR signaling. Downregulation of EGFR in DRG neurons in acute arthritis may limit nociception, but pronounced delayed activation of EGFR in the spinal cord may be involved in chronic inflammatory pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsInterleukin-6Sensory Receptor CellsSpinal CordAnimalsFemaleMiceRatsArthritisArthritis, ExperimentalCell LineGanglia, SpinalGefitinibReceptors, Interleukin-6Signal TransductionSTAT3 Transcription Factor

Stichwörter der Autor:innen

DRGEGFEGFRIL-6 signalingarthritisarthritis painmicrogliapainsoluble IL-6 receptorspinal cord

Substanzen

EGFR protein, mouseEgfr protein, ratErbB ReceptorsGefitinibInterleukin-6interleukin-6, mouseReceptors, Interleukin-6STAT3 Transcription FactorIl6 protein, rat

Autor:innen und Institutionen

  • Institute of Physiology 1/Neurophysiology, Jena University Hospital, Friedrich-Schiller-University, 07743 Jena, Germany.
  • Department of Trauma, Hand and Reconstructive Surgery, Experimental Trauma Surgery, Jena University Hospital, Friedrich-Schiller-University, 07743 Jena, Germany.

ORCID-Profile: Anutosh Roy, Christian König, Annett Eitner, Andrea Ebersberger, Hans-Georg Schaible

Förderung

  • European Union`s Horizon 2020 Research and Innovation Programme
  • European Union’s Horizon 2020 research and innovation program
  • Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, program Neuroimpa)

Zitieren

APA

Roy, A., Segond von Banchet, G., Gimeno-Ferrer, F., König, C., Eitner, A., Ebersberger, A., Ebbinghaus, M., Leuchtweis, J., & Schaible, H. G. (2024). Impact of Interleukin-6 Activation and Arthritis on Epidermal Growth Factor Receptor (EGFR) Activation in Sensory Neurons and the Spinal Cord. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137168

Vancouver

Roy A, Segond von Banchet G, Gimeno-Ferrer F, König C, Eitner A, Ebersberger A, et al. Impact of Interleukin-6 Activation and Arthritis on Epidermal Growth Factor Receptor (EGFR) Activation in Sensory Neurons and the Spinal Cord. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137168

BibTeX
@article{Roy2024,
  author = {Roy, Anutosh and Segond von Banchet, Gisela and Gimeno-Ferrer, Fátima and König, Christian and Eitner, Annett and Ebersberger, Andrea and Ebbinghaus, Matthias and Leuchtweis, Johannes and Schaible, Hans-Georg},
  title = {Impact of Interleukin-6 Activation and Arthritis on Epidermal Growth Factor Receptor (EGFR) Activation in Sensory Neurons and the Spinal Cord},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25137168}
}
Kostenlos starten →